Sector revisions Divi's Laboratories Limited

Equities

Market Closed - NSE India S.E. Other stock markets 04:35:02 09/03/2026 pm IST			5-day change	1st Jan Change
6,330.00 ^INR	+0.02%		-1.22%	-0.98%

12/02	Jefferies Adjusts Divi's Laboratories' Price Target to INR8,100 From INR8,000, Keeps at Buy	MT
11/02	Divi's Laboratories Limited, Q3 2026 Earnings Call, Feb 11, 2026

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	DIVI'S LABORATORIES LIMITED							31
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							24
	ABBVIE INC.							29
	ROCHE HOLDING AG							19
	NOVARTIS AG							21
	ASTRAZENECA PLC							21
	MERCK & CO., INC.							27
	AMGEN INC.							28
	GILEAD SCIENCES, INC.							27
	NOVO NORDISK A/S							21
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							25
	VERTEX PHARMACEUTICALS INCORPORATED							27
	GSK PLC							20
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	HALEON PLC							16
	Average							23
	Weighted average by Cap.							25